TipRanks
Go Ultimate55% OFF

Restart Life Sciences (NMLSF) Income Statement

Restart Life Sciences Income Statement

Last quarter (Q2 2026), Restart Life Sciences's total revenue was $331.16K. In Q2, Restart Life Sciences's net income was $-1.02M. See Restart Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Mar 23Mar 22
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 25.41K$ -3.79K$ -5.00K
$ 1.35M$ 658.51K$ 1.26M$ 1.94M$ 2.93M
Depreciation and Amortization$ 1.85K$ 2.31K$ 2.94K$ 3.79K$ 5.00K
$ -1.34M$ -656.20K$ -1.20M$ -1.84M$ -2.68M
$ -1.35M$ -658.51K$ -1.23M$ -1.94M$ -2.93M
$ -45.22K$ 883.26K$ 7.74K$ -527.00K$ 249.46K
$ -1.39M$ 224.75K$ -1.22M$ -2.47M$ -2.68M
$ -1.39M$ 224.75K$ -1.22M$ -3.76M$ -2.68M
Per Share Metrics
Basic EPS$ -0.04$ 0.01$ -0.01$ -0.02$ -0.02
Diluted EPS$ -0.04$ 0.01$ -0.01$ -0.02$ -0.02
Weighted Average Shares Outstanding33.90M15.29M146.76M136.56M111.10M
Weighted Average Shares Outstanding (Diluted)33.90M16.11M146.76M136.56M111.10M

Currency in CAD

Restart Life Sciences Earnings and Revenue History

-30M-15M015M-240000 %-160000 %-80000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin